Ipca Laboratories consolidated net profit declines 19.28% in the March 2022 quarter

Sales rise 15.65% to Rs 1289.10 crore

Net profit of Ipca Laboratories declined 19.28% to Rs 130.23 crore in the quarter ended March 2022 as against Rs 161.34 crore during the previous quarter ended March 2021. Sales rose 15.65% to Rs 1289.10 crore in the quarter ended March 2022 as against Rs 1114.66 crore during the previous quarter ended March 2021.

For the full year,net profit declined 22.45% to Rs 884.08 crore in the year ended March 2022 as against Rs 1140.01 crore during the previous year ended March 2021. Sales rose 7.56% to Rs 5829.79 crore in the year ended March 2022 as against Rs 5419.99 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear Ended Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales1289.101114.66 16 5829.795419.99 8 OPM %17.0120.54 -22.4628.49 - PBDT230.49247.13 -7 1368.141598.15 -14 PBT169.55194.63 -13 1135.721388.98 -18 NP130.23161.34 -19 884.081140.01 -22

Powered by Capital Market - Live News